Beretta Holding Proposes Partial Tender Offer for 20.05% of Ruger Shares, Demands Poison Pill Exemption
RGR sits 54% above its 52-week low of $28.33 on elevated volume (2.3× avg).
Summary
Activist investor Beretta Holding S.A. has formally proposed an all-cash partial tender offer to acquire an additional 20.05% of Sturm, Ruger & Co. shares at $44.80 per share, conditional on the Board granting an exemption from its "poison pill" rights plan.
Key Events · Ownership and Investor Activity · RGR
-
Partial Tender Offer Proposed
Beretta Holding S.A. proposes an all-cash partial tender offer to acquire an additional 20.05% of Sturm, Ruger & Co.'s outstanding shares, which would increase its total beneficial ownership to 30%.
-
Offer Price at Premium
The offer is for $44.80 per share, representing a significant premium of approximately 20% to the 60-day average price (VWAP).
-
Demand for Poison Pill Exemption
The tender offer is conditional on Ruger's Board granting an exemption from its "poison pill" rights plan by March 31, 2026.
-
Escalation of Activist Campaign
This proposal marks a significant escalation in the ongoing proxy fight and activist campaign by Beretta Holding, following previous proxy solicitations and a recent 13D/A filing on the same day.
Analysis · RGR · Manufacturing
This filing escalates the ongoing proxy battle between activist investor Beretta Holding S.A. and Sturm, Ruger & Co. The proposed partial tender offer, valued at approximately $143 million and representing over 20% of Ruger's market capitalization, aims to increase Beretta's stake to 30%. The explicit demand for an exemption from the company's poison pill by March 31, 2026, puts significant pressure on Ruger's Board, forcing a critical decision that will determine the immediate future of the company's control and strategic direction. Investors should closely monitor the Board's response and the potential for further escalation or negotiation.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 40.1% of the 367 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.64%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RGR was trading at $43.53 on NYSE in the Manufacturing sector, with a market capitalization of approximately $694.1M. The 52-week trading range was $28.33 to $48.21. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.